Addition of Trastuzumab to Paclitaxel After AC Chemotherapy Associated With Significantly Improved OS and DFS: Final Joint Analysis of NSABP B-31 and NCCTG N9831

Capsule Summary - The significant improvement in OS and DFS patients with high-risk HER2-positive early breast cancer was seen across multiple patient subsets.
Source: Clinical Care Options Oncology - Breast Cancer - Category: Cancer & Oncology Source Type: research